Latanoprost Yonsung UD 50 μg/ml
Latanoprost Yonsung UD 50 μg/ml is a medicine authorised by Swissmedic under authorisation number 70284. The authorisation holder is Yonsung AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 September 2025 and the authorisation is limited until 15 September 2030. ATC code S01EE01 places the medicine in the group Ophthalmologicals.
| Authorisation number | 70284 |
|---|---|
| Name | Latanoprost Yonsung UD 50 μg/ml |
| Full name | Latanoprost Yonsung UD 50 μg/ml, Augentropfen, Lösung im Einzeldosisbehältnis |
| Authorisation holder | Yonsung AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | S01EE01 |
| First authorisation | 16 September 2025 |
| Authorisation validity | 15 September 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Latanoprost Yonsung UD 50 μg/ml, Augentropfen, Lösung im Einzeldosisbehältnis | B | 16 September 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 3 x 10 ml | Einzeldose(n) | S01EE01 | 11.09.0. | B |
| 2 | 9 x 10 ml | Einzeldose(n) | S01EE01 | 11.09.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Frequently asked questions
Is Latanoprost Yonsung UD 50 μg/ml authorised in Switzerland?
Yes. Latanoprost Yonsung UD 50 μg/ml is authorised by Swissmedic under authorisation number 70284, data as of 01 September 2026. The authorisation is limited until 15 September 2030.
Which dispensing category does Latanoprost Yonsung UD 50 μg/ml have?
Latanoprost Yonsung UD 50 μg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Latanoprost Yonsung UD 50 μg/ml?
The authorisation holder is Yonsung AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.